Aclaris Therapeutics Inc (ACRS)
R&D to Revenue
1157.15%
Quarterly · Period ending:
ACRS R&D to Revenue
Latest reported1157.15%period ending
Latest reported1157.15%period ending
ACRS Quarterly R&D/Revenue (0.00% → 1157.15%)
Latest values, visible window
High-resolution chart · PNG
ACRS r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 1,157.1516% | |
| 784.4188% | |
| 1,280.6178% | |
| 394.9075% | |
| 644.2881% | |
| 796.1512% | |
| 97.9915% | |
| 137.0456% | |
| 316.6667% | |
| 410.5505% | |
| 151.6562% | |
| 257.229% | |
| 1,352.3274% | |
| 893.4731% | |
| 271.7916% | |
| 124.3874% | |
| 1,228.9921% | |
| 984.5836% | |
| 939.507% | |
| 842.4352% | |
| 432.9496% | |
| 441.0805% | |
| 566.7722% | |
| 430.6418% | |
| 316.0313% | |
| 545.629% | |
| 1,056.1644% | |
| 1,646.2869% | |
| 300.4604% | |
| 395.1399% | |
| 532.4884% | |
| 978.5627% | |
| 380.4135% | |
| 1,216.9946% | |
| 1,320.2202% | |
| 1,588.3041% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |